Malik Shahzad
Insider CIK 1380178 · AGEN Director · CNAT Director, 10% owner · VSAR Director, 10% owner · AFIB Director · AXNX Director · ITRM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AFIB Acutus Medical, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 812,683 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 7,242 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 312,840 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 13,195 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 171,695 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 34,261 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 254,495 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 10,738 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,551,713 | — | $0 | 1,551,713 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 65,436 | — | $0 | 65,436 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $53000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1495000.00 | $0 | 0 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-09-12 | 2019-09-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 19,671 | — | $0 | 19,671 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2018-12-06 | 2018-12-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2018-12-06 | 2018-12-10 | 2,500 | — | $0 | 2,500 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 36,518 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 1,025,981 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 12,010 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 337,447 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 1,231,178 | — | $0 | 1,275,000 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 14,412 | — | $0 | 1,289,412 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 404,937 | — | $0 | 1,694,349 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 43,822 | — | $0 | 43,822 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 391,147 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 13,921 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 218,338 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 7,771 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 13,921 | — | $0 | 13,921 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 8,144 | $13.00 | $105.9K | 29,836 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 7,771 | — | $0 | 21,692 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 391,147 | — | $0 | 391,147 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 218,338 | — | $0 | 609,485 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 228,840 | $13.00 | $2.97M | 838,325 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 11,241 | — | $0 | 11,241 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-12-20 | 2017-12-22 | 11,200 | — | $0 | 23,880 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-05-25 | 2017-06-06 | 6,850 | — | $0 | 6,850 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-05-25 | 2017-06-06 | 3,480 | — | $0 | 12,680 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-17 | 2017-03-17 | 386,367 | $18.01 | $6.96M | 1,621,558 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-16 | 2017-03-17 | 97,303 | $18.50 | $1.80M | 2,007,925 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-15 | 2017-03-15 | 103,122 | $19.08 | $1.97M | 2,105,228 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-14 | 2017-03-15 | 100 | $19.03 | $1.9K | 2,255,128 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-14 | 2017-03-15 | 46,778 | $19.00 | $888.8K | 2,208,350 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-13 | 2017-03-15 | 16,330 | $19.42 | $317.1K | 2,255,228 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-06-23 | 2016-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-06-15 | 2016-06-17 | 35,000 | $3.91 | $136.8K | 35,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-05-18 | 2016-05-20 | 14,625 | — | $0 | 14,625 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-05-18 | 2016-05-20 | 4,625 | — | $0 | 9,200 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2015-06-29 | 2015-07-01 | 13,100 | — | $0 | 13,100 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2015-06-29 | 2015-07-01 | 4,575 | — | $0 | 4,575 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2015-06-25 | 2015-06-29 | 18,750 | $8.43 | $158.1K | 18,750 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGEN AGENUS INC | J Other | 2015-05-27 | 2015-05-27 | 1,587,302 | $6.30 | $10.00M | 1,587,302 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-04-29 | 2015-04-30 | 407,377 | $7.02 | $2.86M | 0 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-04-28 | 2015-04-30 | 700,000 | $7.16 | $5.01M | 407,377 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2015-01-22 | 2015-01-26 | 55,000 | $17.25 | $948.8K | 2,271,558 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGEN AGENUS INC | J Other | 2014-05-08 | 2015-04-30 | 111,289 | $3.00 | $333.9K | 1,107,377 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2014-04-24 | 2014-04-29 | 15,000 | $2.71 | $40.6K | 15,000 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-27 | 1,773,049 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-27 | 899,619 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-27 | 2,033,350 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-27 | 5,626,413 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-27 | 14,468,020 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | X Exercise deriv | 2014-03-26 | 2014-03-27 | 506,376 | — | $0 | 14,468,020 | SEC↗ |
| VSAR Versartis, Inc. | X Exercise deriv | 2014-03-26 | 2014-03-27 | 506,376 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-27 | 1,258,086 | — | $0 | 1,258,086 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-26 | 2014-03-27 | 60,000 | $21.00 | $1.26M | 2,216,558 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-27 | 489,253 | — | $0 | 1,747,339 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-27 | 176,813 | — | $0 | 1,924,152 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-27 | 78,228 | — | $0 | 2,002,380 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-27 | 154,178 | — | $0 | 2,156,558 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2014-03-20 | 2014-03-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2014-03-13 | 2014-03-17 | 25,000 | $4.08 | $102.0K | 25,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | X Exercise deriv | 2013-07-30 | 2013-08-01 | 577,599 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,576,786 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 10,000,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | S Sale | 2013-07-30 | 2013-08-01 | 535 | $11.00 | $5.9K | 1,957,559 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2013-07-30 | 2013-08-01 | 19,223 | $11.00 | $211.5K | 1,976,782 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2013-07-30 | 2013-08-01 | 190,054 | $11.00 | $2.09M | 2,166,836 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | X Exercise | 2013-07-30 | 2013-08-01 | 70,003 | $0.08 | $5.6K | 1,958,094 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 1,888,091 | — | $0 | 1,888,091 | SEC↗ |